Literature DB >> 10577359

Biosynthesis and inactivation of N-arachidonoylethanolamine (anandamide) and N-docosahexaenoylethanolamine in bovine retina.

T Bisogno1, I Delton-Vandenbroucke, A Milone, M Lagarde, V Di Marzo.   

Abstract

N-Arachidonoylethanolamine (anandamide; AEA) and 2-arachidonoylglycerol (2-AG), the two proposed endogenous agonists of cannabinoid receptors, and the putative AEA biosynthetic precursor, N-arachidonoylphosphatidylethanolamine (NArPE), were identified in bovine retina by means of gas chromatography-electron impact mass spectrometry (GC-EIMS). This technique also allowed us to identify N-docosahexanoylethanolamine (DHEA) and 2-docosahexanoylglycerol (2-DHG), two derivatives of docosahexaenoic acid (DHA), one of the most abundant fatty acids esterified in retina phospholipids and necessary for optimal retinal function. N-Docosahexaenoylphosphatidylethanolamine (NDHPE), the potential biosynthetic precursor for DHEA, was also found. The fatty acid composition of the sn-1 and sn-2 positions of bovine retina's most abundant phospholipid classes, also determined here, were in agreement with a phospholipid-dependent mechanism for 2-AG, 2-DHG, AEA, and DHEA biosynthesis, as very high levels of polyunsaturated fatty acids, including DHA, were found on the sn-2 position of phosphatidylcholine (PC) and -ethanolamine (PE), and measurable amounts of di-docosahexanoyl-PC and -PE, two potential biosynthetic precursors of NDHPE, were detected. Accordingly, we found that isolated particulate fractions from bovine retina could release AEA and DHEA in a time-dependent fashion. Finally, a fatty acid amide hydrolase (FAAH)-like activity with subcellular distribution and pH dependency similar to those reported for the brain enzyme was also detected in bovine retina. This activity was inhibited by FAAH inhibitors, phenylmethylsulfonyl fluoride and arachidonoyltrifluoromethylketone, and appeared to recognize DHEA with a lower efficiency than AEA. These data indicate that AEA and its congeners may play a physiological role in the mammalian eye.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10577359     DOI: 10.1006/abbi.1999.1410

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  31 in total

1.  Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets.

Authors:  A Berger; G Crozier; T Bisogno; P Cavaliere; S Innis; V Di Marzo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

2.  Lipid transport function is the main target of oral oleoylethanolamide to reduce adiposity in high-fat-fed mice.

Authors:  Clémentine Thabuis; Frédéric Destaillats; Didier M Lambert; Giulio G Muccioli; Matthieu Maillot; Touafiq Harach; Delphine Tissot-Favre; Jean-Charles Martin
Journal:  J Lipid Res       Date:  2011-04-24       Impact factor: 5.922

3.  Identification of prostamides, fatty acyl ethanolamines, and their biosynthetic precursors in rabbit cornea.

Authors:  Paula Urquhart; Jenny Wang; David F Woodward; Anna Nicolaou
Journal:  J Lipid Res       Date:  2015-05-31       Impact factor: 5.922

Review 4.  Therapeutic implications of disorders of cell death signalling: membranes, micro-environment, and eicosanoid and docosanoid metabolism.

Authors:  J Davidson; D Rotondo; M T Rizzo; H A Leaver
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

Review 5.  Lysophosphatidylcholine as a preferred carrier form of docosahexaenoic acid to the brain.

Authors:  M Lagarde; N Bernoud; N Brossard; D Lemaitre-Delaunay; F Thiès; M Croset; J Lecerf
Journal:  J Mol Neurosci       Date:  2001 Apr-Jun       Impact factor: 3.444

6.  Inhibition of COX-2-mediated eicosanoid production plays a major role in the anti-inflammatory effects of the endocannabinoid N-docosahexaenoylethanolamine (DHEA) in macrophages.

Authors:  Jocelijn Meijerink; Mieke Poland; Michiel G J Balvers; Pierluigi Plastina; Carolien Lute; Jvalini Dwarkasing; Klaske van Norren; Renger F Witkamp
Journal:  Br J Pharmacol       Date:  2014-09-23       Impact factor: 8.739

Review 7.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

8.  Endogenous Bioactive Lipids and the Regulation of Conventional Outflow Facility.

Authors:  Zhou Wan; David F Woodward; W Daniel Stamer
Journal:  Expert Rev Ophthalmol       Date:  2008

Review 9.  Biological functions and metabolism of oleoylethanolamide.

Authors:  Clémentine Thabuis; Delphine Tissot-Favre; Jean-Baptiste Bezelgues; Jean-Charles Martin; Cristina Cruz-Hernandez; Fabiola Dionisi; Frédéric Destaillats
Journal:  Lipids       Date:  2008-08-13       Impact factor: 1.880

10.  Agonist-dependent cannabinoid receptor signalling in human trabecular meshwork cells.

Authors:  B T McIntosh; B Hudson; S Yegorova; C A B Jollimore; M E M Kelly
Journal:  Br J Pharmacol       Date:  2007-10-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.